Bioengineered baculoviruses as new class of therapeutics using micro and nanotechnologies: principles, prospects and challenges

Arghya Paul; Anwarul Hasan; Laetitia Rodes; Mugundhine Sangaralingam; Satya Prakash

doi:10.1016/j.addr.2014.01.004

Bioengineered baculoviruses as new class of therapeutics using micro and nanotechnologies: principles, prospects and challenges

Adv Drug Deliv Rev. 2014 May:71:115-30. doi: 10.1016/j.addr.2014.01.004. Epub 2014 Feb 3.

Authors

Arghya Paul¹, Anwarul Hasan², Laetitia Rodes³, Mugundhine Sangaralingam³, Satya Prakash⁴

Affiliations

¹ Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill University, 3775 University Street, Montreal, Québec H3A 2B4, Canada; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Center for Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA 02139, USA.
² Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Center for Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA 02139, USA.
³ Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill University, 3775 University Street, Montreal, Québec H3A 2B4, Canada.
⁴ Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering and Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill University, 3775 University Street, Montreal, Québec H3A 2B4, Canada. Electronic address: satya.prakash@mcgill.ca.

PMID: 24503281
DOI: 10.1016/j.addr.2014.01.004

Abstract

Designing a safe and efficient gene delivery system is required for success of gene therapy trials. Although a wide variety of viral, non-viral and polymeric nanoparticle based careers have been widely studied, the current gene delivery vehicles are limited by their suboptimal, non-specific therapeutic efficacy and acute immunological reactions, leading to unwanted side effects. Recently, there has been a growing interest in insect-cell-originated baculoviruses as gene delivery vehicles for diverse biomedical applications. Specifically, the emergence of diverse types of surface functionalized and bioengineered baculoviruses is posed to edge over currently available gene delivery vehicles. This is primarily because baculoviruses are comparatively non-pathogenic and non-toxic as they cannot replicate in mammalian cells and do not invoke any cytopathic effect. Moreover, emerging advanced studies in this direction have demonstrated that hybridizing the baculovirus surface with different kinds of bioactive therapeutic molecules, cell-specific targeting moieties, protective polymeric grafts and nanomaterials can significantly improve the preclinical efficacy of baculoviruses. This review presents a comprehensive overview of the recent advancements in the field of bioengineering and biotherapeutics to engineer baculovirus hybrids for tailored gene therapy, and articulates in detail the potential and challenges of these strategies for clinical realization. In addition, the article illustrates the rapid evolvement of microfluidic devices as a high throughput platform for optimizing baculovirus production and treatment conditions.

Keywords: Biomaterials; Cardiovascular; Gene therapy; Nanomedicine; Tissue engineering.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Baculoviridae / genetics*
Bioengineering / methods
Equipment Design
Gene Transfer Techniques*
Genetic Therapy / methods*
Genetic Vectors
High-Throughput Screening Assays
Humans
Microfluidics
Microtechnology / methods
Nanotechnology / methods
Polymers / chemistry

Substances

Polymers

Grants and funding

MOP 93641/Canadian Institutes of Health Research/Canada